Chemed Net Worth 2010-2025 | CHE

Interactive chart of historical net worth (market cap) for Chemed (CHE) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Chemed net worth as of June 25, 2025 is $8.08B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.083B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.944B 19.65
Encompass Health (EHC) United States $12.163B 25.78
DaVita (DVA) United States $10.597B 14.90
Elanco Animal Health (ELAN) United States $6.834B 14.64
Option Care Health (OPCH) United States $5.206B 23.20
RadNet (RDNT) United States $4.209B 267.14
Amedisys (AMED) United States $3.219B 21.65
Addus HomeCare (ADUS) United States $2.087B 22.91
LifeStance Health (LFST) United States $1.925B 0.00
Astrana Health (ASTH) United States $1.404B 34.78
U.S Physical Therapy (USPH) United States $1.191B 30.76
Pennant (PNTG) United States $1.005B 36.90
Aveanna Healthcare Holdings (AVAH) United States $0.948B 54.00
Atai Life Sciences (ATAI) Germany $0.441B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.041B 0.00
Ontrak (OTRK) United States $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00